StatinsRelative risk=0.84P=.04895%CI 0.701-0.999AtorvastatinPlacebo0510150481216Time Since Randomization(weeks)Cumulative Incidence(%)Time to first occurrence of:Death(any cause)Nonfatal MIResuscitated cardiac arrestWorsening angina with new objective evidence and urgent rehospitalization17.4%14.8%Primary Efficacy MeasureSchwartz GG,et al.JAMA.2001;285:1711-1718.-11.1%42.7%39.6%48.9%42.1%35.530.26.33.84.003.002.001.000.00追蹤時間（月）追蹤時間（月）1.00.80.60.40.20.0Cum SurvivalCum SurvivalLate group-censoredEarly group-censoredLate groupEarly groupgroup
